Olink Bioscience Proseek Multiplex CVD II 96x96 and Proseek Multiplex CVD III 96x96

Olink Biosciences has launched two new protein biomarker panels, Proseek Multiplex CVD II 96x96 and Proseek Multiplex CVD III 96x96. The panels expand on Olink Biosciences' existing panel that targets a wide range of cardiovascular-related diseases and double the number of CVD-associated biomarkers that can be assayed to 184. These panels are high-throughput multiplex immunoassays that each measure 93 CVD-related proteins across 96 samples simultaneously using only one microliter of serum, plasma, or almost any other type of biological sample. When used with the Fluidigmn Biomark HD system, a high-throughput real-time PCR platform, it enables researchers to analyze thousands of samples per week, which greatly accelerates the speed of protein biomarker research, Olink said in a statement.